SMTL ID : 4umu.1

Structure of MELK in complex with inhibitors

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.02 Å

Oligo State

monomer

Ligands

1 x 0V0: (2-ETHOXY-4-{[3-(ISOQUINOLIN-7-YL)PROP-2-YN-1-YL]OXY}PHENYL)METHANAMINIUM(Non-covalent)

0V0.1: 21 residues within 4Å: Chain A: I.37, V.45, A.58, E.77, I.78, L.81, L.84, I.89, C.90, M.104, L.106, E.107, Y.108, C.109, V.143, H.150, L.159, L.168, I.169, D.170, F.171 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.45, A:L.81, A:L.81, A:L.84, A:I.89, A:L.159, A:L.168, A:I.169, A:I.169, A:D.170 Hydrogen bonds: A:C.109, A:D.170, A:D.170 pi-Stacking: A:F.171

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Johnson, C.N. et al., Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase. Acs Med.Chem.Lett. (2015)

Release Date

2014-10-22

Peptides

MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE

Related Entries With Identical Sequence